Scleroderma, Diffuse - 12 Studies Found

Completed : Nilotinib in the Treatment of Systemic Sclerosis
: Systemic Sclerosis
: 2010-07-01
: Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months.
Active, not recruiting : Taking Charge of Systemic Sclerosis
: Scleroderma
: 2015-05-22
:
  • Other: Internet-based self-management program
Completed : Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
: Systemic Sclerosis
: 2007-11-07
: Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont
Completed : Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
: Systemic Sclerosis
: 2008-04-25
Completed : Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis
: Scleroderma
: 2012-06-18
: Drug: Campath Pediatric patients with dcSSc are eligible for the clinical trial if they fulfill the incl
Completed : Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
: Systemic Sclerosis
: 2008-04-23
Completed : A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
:
  • Scleroderma, Diffuse
  • Scleroderma,
    : 2007-03-01
    :
    • Drug: Abatacept Active drug, a
Completed : Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
: Scleroderma, Systemic
: 2006-06-02
: Drug: Mycophenolate mofetil
Completed : Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
: Scleroderma
: 2011-09-29
:
  • Procedure: Cytoxan rATG/Fludarabine/HSCT

Completed : Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
: Systemic Scleroderma
: 2015-01-18
:
  • Drug: C-82 Topical Gel, 1% act
Next >>>